| RESMED INC. DL-,004 |
| USA |
| Gesundheit |
| US7611521078 / 895878 |
| RME (Frankfurt) / RMD (NYSE) |
| FRA:RME, ETR:RME, RME:GR, NYSE:RMD |
| S&P500 |
| https://investor.resmed.c.. |
|
ResMed Inc. is a global medical technology company that develops, manufactures, and markets advanced medical devices and cloud-based software solutions for diagnosing, treating, and managing respiratory and sleep disorders. The company operates throu..
>Volltext.. |
| 28124.41 Mio. EUR |
| 27631.95 Mio. EUR |
| 4676.47 Mio. EUR |
| 1812.06 Mio. EUR |
| 1287.24 Mio. EUR |
| 8.8 EUR |
| 734.39 Mio. EUR |
| 1227.63 Mio. EUR |
| 1658.55 Mio. EUR |
| 1.14 |
| -3.43% |
| 4.88% |
| 1.99 EUR |
| 1.06% |
| 1.08% |
| 12.02.26 - 0.50544006€ 13.11.25 - 0.51762€ >weitere anzeigen... |
| RESMED |
| 03.04.26 |
|
||||
|
||||
|